Salivary diagnostics powered by nanotechnologies, proteomics and genomics.

BACKGROUND The ability to monitor health status, disease onset and progression, and treatment outcome through noninvasive means is a highly desirable goal in health care promotion and delivery. Oral fluid is a perfect medium to be explored for health and disease surveillance. METHODS Two prerequisites exist before the goal of salivary diagnostics can be achieved: identification of specific biomarkers associated with a health or disease state and the development of technologies that can discriminate between the biomarkers. A recent initiative of the National Institute of Dental and Craniofacial Research has created a roadmap to achieve these goals through the use of oral fluids as the diagnostic medium to scrutinize the health and/or disease status of patients. This is an ideal opportunity to optimize state-of-the-art saliva-based biosensors for salivary biomarkers that discriminate between diseases. RESULTS Seven technology groups are developing point-of-care salivary diagnostic technologies. Three groups are working together toward deciphering the salivary proteome. CONCLUSION These collective efforts and the convergence of salivary diagnostic technologies and the salivary proteome will present unparalleled opportunities to explore the diagnostic potential of saliva for oral and systemic diseases.

[1]  R. Haeckel,et al.  Application of saliva for drug monitoring. An in vivo model for transmembrane transport. , 1996, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[2]  I. Mandel,et al.  Salivary diagnosis: more than a lick and a promise. , 1993, Journal of the American Dental Association.

[3]  D. T. Wong,et al.  Large‐scale identification of proteins in human salivary proteome by liquid chromatography/mass spectrometry and two‐dimensional gel electrophoresis‐mass spectrometry , 2005, Proteomics.

[4]  S. Reynolds,et al.  OraQuick® ADVANCE Rapid HIV-1/2 antibody test , 2004, Expert review of molecular diagnostics.

[5]  J. Parry,et al.  Detection of antibody to HIV in saliva: a brief review. , 1994, Clinical and diagnostic virology.

[6]  A. Carr,et al.  Systemic assessments utilizing saliva: part 1 general considerations and current assessments. , 2006, The International journal of prosthodontics.

[7]  D. Malamud,et al.  Detection of Human Immunodeficiency Virus Antibodies in Oral Fluids , 1998, Clinical Diagnostic Laboratory Immunology.

[8]  G. Duff,et al.  The interleukin-1 genotype as a severity factor in adult periodontal disease. , 1997, Journal of clinical periodontology.

[9]  H. Craighead,et al.  Powering an inorganic nanodevice with a biomolecular motor. , 2000, Science.

[10]  Carlo Montemagno,et al.  Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. , 2004, Archives of otolaryngology--head & neck surgery.

[11]  David Elashoff,et al.  Serum circulating human mRNA profiling and its utility for oral cancer detection. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  P. Denny,et al.  Salivary mucin as related to oral Streptococcus mutans in elderly people. , 2000, Oral microbiology and immunology.

[13]  David Elashoff,et al.  Salivary Transcriptome Diagnostics for Oral Cancer Detection , 2004, Clinical Cancer Research.

[14]  D. Wong,et al.  RNA Profiling of Cell-free Saliva Using Microarray Technology , 2004, Journal of dental research.

[15]  S. Socransky,et al.  Microbiological parameters associated with IL-1 gene polymorphisms in periodontitis patients. , 2000, Journal of clinical periodontology.

[16]  S. Miller Saliva testing--a nontraditional diagnostic tool. , 1994, Clinical laboratory science : journal of the American Society for Medical Technology.